Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Efthalia Angelopoulou
ResearcherPublications, citations & collaboration network
Efthalia Angelopoulou is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 132 works, 3,617 citations, an h-index of 34 and an i10-index of 75.
132
Works
3,617
Citations
34
h-index
75
i10-index
How has Efthalia Angelopoulou's publication output changed over time?
ScholarIQpublication output · 2019–2023
Output declined75% over the shown period — from 4 works in 2019 to 1 in 2023.
4
4
2
1
1
20192020202120222023
What are the most-cited papers on Efthalia Angelopoulou?
ScholarIQmost cited works
Revisiting the role of neurotransmitters in epilepsy: An updated review
Enes Akyüz, Ayse Kristina Polat, Ece Eroğlu, İ̇rem Küllü, Efthalia Angelopoulou, Yam Nath Paudel
Life Sciences. 2020299 Citations
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Iekhsan Othman, Khurram Aamir, Mohd. Farooq Shaikh
S2736626452. 2020255 CitationsOPEN ACCESS
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Vinod Balasubramaniam, Iekhsan Othman, Mohd. Farooq Shaikh
European Journal of Pharmacology. 2019175 Citations
miR-124 and Parkinson’s disease: A biomarker with therapeutic potential
Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
Pharmacological Research. 2019147 Citations
Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Mohd. Farooq Shaikh, Iekhsan Othman
Pharmacological Research. 2019118 Citations
Related on ScholarIQ
National and Kapodistrian University of Athens
Institution
Revisiting the role of neurotransmitters in epilepsy: An updated review
Paper
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Paper
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
Paper
miR-124 and Parkinson’s disease: A biomarker with therapeutic potential
Paper
Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
Paper